The Portsmouth Redevelopment and Housing Authority has opened Lexington Reserve, a new senior living community. Located on ...

Universities and research labs have long been Europe’s deep tech treasure trove. Now, academic spinouts have consolidated into a solid startup funnel worth $398 billion — and VC money is following.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer behind ...

The life sciences sector continues to be a linchpin of the Republic’s foreign direct investment strategy and indeed, the wider economy. More than 700 biopharma, medtech, and digital health companies ...

It wasn't hard to be optimistic about the biotech's future, given its excellent news from the lab on Monday. Prognosticators fell over themselves publishing bullish new takes on the company the ...

Human biology evolved for a world of movement, nature, and short bursts of stress—not the constant pressure of modern life. Industrial environments overstimulate our stress systems and erode both ...

The biotech's investigational weight loss drug did very well in a clinical trial. This is a white-hot segment of the pharmaceutical market, so it's little wonder investors subsequently pounced on the ...

Scientists have discovered that complex life began evolving much earlier than traditional models suggested. Using an expanded molecular clock approach, the team showed that crucial cellular features ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

To admire is a form of exposure. The moment we declare our fascination, we disclose the private coordinates of taste and longing: what we find desirable, what we forgive, what we wish to be. Fandom is ...

Generic drugmaker Granules India subsidiary Granules Life Sciences (GLS), located in Hyderabad, has received U.S. Food and Drug Administration (U.S. FDA) approval for a product that earlier this year ...

Tiziana Life Sciences' Foralumab intranasal anti-CD3 targets the Treg–microglia axis. However, their intranasal delivery makes them unique and patient-friendly. Foralumab has a Phase 2 for SPMS, a ...